Benralizumab
Product Specifications
CAS Number
1044511-01-4
Target
IL Receptor|||Apoptosis|||Interleukin
Related Pathways
Apoptosis|||Immunology/Inflammation
Purity
>95%
Bioactivity
Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5R?) . It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
